Phio Pharmaceuticals
PHIO
#10946
Rank
A$13.59 M
Marketcap
A$1.14
Share price
-5.03%
Change (1 day)
-43.69%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -A$18.93 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$12.84 Million a decrease over its 2024 earnings that were of -A$10.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$18.93 Million47.47%
2025 -A$12.84 Million21.65%
2024 -A$10.56 Million-33.96%
2023 -A$15.98 Million-5.7%
2022 -A$16.95 Million-13.6%
2021 -A$19.61 Million51.09%
2020 -A$12.98 Million-1.28%
2019 -A$13.15 Million21.03%
2018 -A$10.87 Million-53.1%
2017 -A$23.16 Million74.49%
2016 -A$13.28 Million-12.02%
2015 -A$15.09 Million16.17%
2014 -A$12.99 Million-57.95%
2013 -A$30.88 Million62.45%
2012 -A$19.01 Million0.87%
2011 -A$18.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 1,133.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.8 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA